UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023120 |
|---|---|
| Receipt number | R000026464 |
| Scientific Title | Open-label, dose-escalating clinical trial of Survivin-responsive conditionally replicative adenovirus (Surv.m-CRA-1) by local administration to evaluate the safety / tolerability and preliminary efficacy in patients with advanced solid tumors (Phase I trial). |
| Date of disclosure of the study information | 2016/07/11 |
| Last modified on | 2019/11/09 18:59:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/07/11 21:52:41 | ||
| 2 | Update | 2016/07/11 21:55:48 | Date of disclosure of the study information |
|
| 3 | Update | 2016/10/14 20:19:36 | Recruitment status |
|
| 4 | Update | 2017/02/21 18:05:28 | ||
| 5 | Update | 2017/03/06 20:16:57 | Key inclusion criteria Key inclusion criteria |
|
| 6 | Update | 2017/03/06 20:17:43 | Recruitment status |
|
| 7 | Update | 2018/01/11 10:07:32 | Recruitment status |
|
| 8 | Update | 2018/09/03 21:35:07 | Recruitment status |
|
| 9 | Update | 2018/09/03 21:36:22 | Last name of lead principal investigator Last name of lead principal investigator |
|
| 10 | Update | 2019/04/22 21:27:26 | Recruitment status Date of IRB Last follow-up date |
|
| 11 | Update | 2019/11/09 18:59:01 | Recruitment status |
